Evidence map›Paper›PMID 36002615›Full record

ArticlePharmaceutical research2023

Biophysical, Molecular and Proteomic Profiling of Human Retinal Organoid-Derived Exosomes.

Peggy Arthur, Sangeetha Kandoi, Li Sun, Anil Kalvala, Shallu Kutlehria, Santanu Bhattacharya, Tanmay Kulkarni, Ramesh Nimma, Yan Li, Deepak A Lamba and 1 more

Open access · greenAbstract read
In one paragraph

Article in Pharmaceutical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Force spectroscopy reveals membrane fluctuations and surface adhesion of extracellular nanovesicles impact their elastic behavior.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  15. Review
  16. Article
  17. Extracellular vesicles: key mediators inFrontiers in veterinary science · 2025
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Peggy ArthurCollege of Pharmacy and Pharmacological Sciences, Florida A&M University, Tallahassee, FL, USA.
Sangeetha KandoiDepartment of Ophthalmology, University of California San Francisco, San Francisco, CA, USA.
Li SunDepartment of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Florida State University, Tallahassee, FL, USA.
Anil KalvalaCollege of Pharmacy and Pharmacological Sciences, Florida A&M University, Tallahassee, FL, USA.
Shallu KutlehriaCollege of Pharmacy and Pharmacological Sciences, Florida A&M University, Tallahassee, FL, USA.
Santanu BhattacharyaDepartment of Biochemistry and Molecular Biology, Mayo College of Medicine and Science, Jacksonville, FL, USA.
Tanmay KulkarniDepartment of Biochemistry and Molecular Biology, Mayo College of Medicine and Science, Jacksonville, FL, USA.
Ramesh NimmaCollege of Pharmacy and Pharmacological Sciences, Florida A&M University, Tallahassee, FL, USA.
Yan LiDepartment of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Florida State University, Tallahassee, FL, USA. yli@eng.famu.fsu.edu.
Deepak A LambaDepartment of Ophthalmology, University of California San Francisco, San Francisco, CA, USA. deepak.lamba@ucsf.edu.
Mandip SinghCollege of Pharmacy and Pharmacological Sciences, Florida A&M University, Tallahassee, FL, USA. mandip.sachdeva@famu.edu.ORCID http://orcid.org/0000-0001-6722-3709
Florida Agricultural and Mechanical University · USFlorida A&M University - Florida State University College of Engineering · USJacksonville College · USUniversity of California, San Francisco · USFlorida State University · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
Tissue CoreP50CA102701 · NCI · MAYO CLINIC ROCHESTER · PI PETERSEN, GLORIA M. · 2004 to 2018
$32.7M
Research Project-3: Effectiveness of an eHealth intervention for uptake of cervical cancer screening in Hispanic womenU54MD007582 · NIMHD · FLORIDA AGRICULTURAL AND MECHANICAL UNIV · PI Eunsook Yu Lee · 2019 to 2026
$28.1M
Rapid-Prototyping and Design CoreP30EY002162 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LAKKARAJU, APARNA · 1985 to 2024
$16.8M
Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision ResearchU24EY029891 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI CARROLL, JOSEPH, DUNCAN, JACQUE LYNNE · 2018 to 2022
$6.6M
Fast myosin binding protein-C and cardiac contractility in heart failureR01HL105826 · NHLBI · UNIVERSITY OF CINCINNATI · PI SADAYAPPAN, SAKTHIVEL · 2011 to 2025
$4.5M
Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA modelR01EY032197 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ULLIAN, ERIK M · 2021 to 2025
$2.5M
Engineering Extracellular Vesicles of Human Brain Organoids for Stroke TherapyR01NS125016 · NINDS · FLORIDA STATE UNIVERSITY · PI Yan Li · 2022 to 2026
$1.8M
NCI NIH HHS P30 CA015083NCI NIH HHS P50 CA102701NEI NIH HHS P30 EY002162NEI NIH HHS R01 EY032197NEI NIH HHS U24 EY029891NHLBI NIH HHS R01 HL105826NIH HHS R01- EY032197NIH HHS R01-NS125016NIH HHS U24 EY029891NIMHD NIH HHS U54 MD007582NINDS NIH HHS R01 NS125016
6 · The paper itself

Abstract

purposeThere is a growing interest in extracellular vesicles (EVs) for ocular applications as therapeutics, biomarkers, and drug delivery vehicles. EVs secreted from mesenchymal stem cells (MSCs) have shown to provide therapeutic benefits in ocular conditions. However, very little is known about the properties of bioreactor cultured-3D human retinal organoids secreted EVs. This study provides a comprehensive morphological, nanomechanical, molecular, and proteomic characterization of retinal organoid EVs and compares it with human umbilical cord (hUC) MSCs.

methodsThe morphology and nanomechanical properties of retinal organoid EVs were assessed using Nanoparticle tracking analysis (NTA) and Atomic force microscopy (AFM). Gene expression analysis of exosome biogenesis of early and late retinal organoids were compared using qPCR. The protein profile of the EVs were analyzed with proteomic tools.

resultsNTA indicated the average size of EV as 100-250 nm. A high expression of exosome biogenesis genes was observed in late retinal organoids EVs. Immunoblot analysis showed highly expressed exosomal markers in late retinal organoids EVs compared to early retinal organoids EVs. Protein profiling of retinal organoid EVs displayed a higher differential expression of retinal function-related proteins and EV biogenesis proteins than hUCMSC EVs, implicating that the use of retinal organoid EVs may have a superior therapeutic effect on retinal disorders.

conclusionThis study provides supplementary knowledge on the properties of retinal organoid EVs and suggests their potential use in the diagnostic and therapeutic treatments for ocular diseases.

Indexed as

ExosomesExtracellular VesiclesHumansOrganoidsProteomicsRetinaBioreactorExtracellular vesiclesHuman retinal organoidsProteomicsStem cells

Identifiers

PMID36002615
PMCPMC10576571
OpenAlexW4293101993

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.